Woburn, MA: Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a strategic partnership with Sartorius Stedim Biotech, a leading provider of cutting-edge products and services for the biopharmaceutical industry. This partnership will enable worldwide availability of a magnetic bead-free T cell activation product built with Quad Technologies’ patented QuickGel® platform. […]
Highlights: • Focused R&D expansion providing core competencies in biosensor chemistries and bioassay solutions targeting pharma/biopharma applications for near and long-term portfolio expansion • Broadens cell analysis portfolio with addition of complementary plate reader-based cellular assays • Accelerates expansion into pharma/biopharma discovery and in vitro toxicology screening applications SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced […]
SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]
AMSBIO has introduced recombinant Wnt3a with a new Wnt stabilizer that significantly extends the activity of this protein in serum-free medium from a half-life of just 2 hours to around 30 hours. Wnt-3a is a protein that is encoded by the Wnt3a gene. The Wnt gene family consists of structurally related genes that encode secreted […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “Atlanta Biologicals is a great fit with the Bio-Techne […]
ACEA Biosciences makes available an exhaustive library of xCELLigence papers spanning 15 years and applications ranging from immune cell killing and cell invasion/migration to viral cytopathic effect and cardiotoxicity screening SAN DIEGO In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell […]
One year. Five new products. 2017 marked another record year for new product launches at Stratedigm. And CellCapTure 4.1—our flow cytometry acquisition and analysis software—is the foundation of Stratedigm’s latest innovations. Never before have such revolutionary products like the patent pending Visual Protocol Designer (VPD), Universal-API for automation, IoT empowered Control Center, and the A800 Cell Incubator (CI) been seamlessly integrated in […]
Madison, WI – Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSC-cells, announced that its iCell® Cardiomyocytes were launched into space via SpaceX’s 13th commercial resupply services mission to the International Space Station on Dec.15, 2017. The purpose of the scientific research […]
WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
